The Thr to Met substitution of amino acid 118 in hepatitis B virus surface antigen escapes from immune-assay-based screening of blood donors

References

1. Bartholomeusz A., Tehan B. G., Chalmers D. K. 2004; Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther 9:149–160[PubMed]
   [Google Scholar]
2. Candotti D., Allain J. P. 2009; Transfusion-transmitted hepatitis B virus infection. J Hepatol 51:798–809 [View Article][PubMed]
   [Google Scholar]
3. Carman W. F. 1997; The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:(Suppl. 1)11–20 [View Article][PubMed]
   [Google Scholar]
4. Carman W. F., Karayiannis P., Waters J., Thomas H. C., Zanetti A. R., Manzillo E., Zuckerman A. J. 1990; Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325–329 [View Article][PubMed]
   [Google Scholar]
5. Deng L., Tang H. 2011; Hepatitis B virus drug resistance to current nucleos(t)ide analogs: mechanisms and mutation sites. Hepatol Res 41:1017–1024 [View Article][PubMed]
   [Google Scholar]
6. Dienstag J. L. 2008; Hepatitis B virus infection. N Engl J Med 359:1486–1500 [View Article][PubMed]
   [Google Scholar]
7. Echevarría J. M., Avellón A. 2008; Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay. J Med Virol 80:598–602 [View Article][PubMed]
   [Google Scholar]
8. Kuhns M. C., Kleinman S. H., McNamara A. L., Rawal B., Glynn S., Busch M. P., REDS Study Group. 2004; Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 44:1332–1339 [View Article][PubMed]
   [Google Scholar]
9. Mangold C. M., Streeck R. E. 1993; Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67:4588–4597[PubMed]
   [Google Scholar]
10. Mizuochi T., Okada Y., Umemori K., Mizusawa S., Yamaguchi K. 2006; Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. J Virol Methods 136:254–256 [View Article][PubMed]
    [Google Scholar]
11. Nan Y., Wang R., Shen M., Faaberg K. S., Samal S. K., Zhang Y. J. 2012; Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 432:261–270 [View Article][PubMed]
    [Google Scholar]
12. Ott J. J., Stevens G. A., Groeger J., Wiersma S. T. 2012; Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30:2212–2219 [View Article][PubMed]
    [Google Scholar]
13. Patel D., Nan Y., Shen M., Ritthipichai K., Zhu X., Zhang Y. J. 2010; Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol 84:11045–11055 [View Article][PubMed]
    [Google Scholar]
14. Radziwill G., Tucker W., Schaller H. 1990; Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64:613–620[PubMed]
    [Google Scholar]
15. Seddigh-Tonekaboni S., Waters J. A., Jeffers S., Gehrke R., Ofenloch B., Horsch A., Hess G., Thomas H. C., Karayiannis P. 2000; Effect of variation in the common a determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60:113–121 [View Article][PubMed]
    [Google Scholar]
16. Shepard C. W., Simard E. P., Finelli L., Fiore A. E., Bell B. P. 2006; Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28:112–125 [View Article][PubMed]
    [Google Scholar]
17. Szmuness W., Stevens C. E., Zang E. A., Harley E. J., Kellner A. 1981; A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1:377–385 [View Article][PubMed]
    [Google Scholar]
18. Tian Y., Xu Y., Zhang Z., Meng Z., Qin L., Lu M., Yang D. 2007; The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45:2971–2978 [View Article][PubMed]
    [Google Scholar]
19. Weber B. 2006; Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78:(Suppl. 1)S59–S65 [View Article][PubMed]
    [Google Scholar]
20. WHO 2015 Hepatitis B fact sheet no. 204 Geneva: WHO;
    [Google Scholar]
21. Zuckerman A. J. 2000; Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355:1382–1384 [View Article][PubMed]
    [Google Scholar]